Functional analysis of naturally occurring amino acid substitutions in human IFN-γR1

Molecular Immunology

Volumn 47, Issue 5, 2010, Pages 1023-1030

  van de Wetering, Diederik ^a   de Paus, Roelof A ^a   van Dissel, Jaap T ^a   van de Vosse, Esther ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

IFN ; IFN R1; Immune deficiency; Mutation; Signal transduction

Indexed keywords

CD64 ANTIGEN; GAMMA INTERFERON; HISTIDINE; HLA ANTIGEN CLASS 1; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON GAMMA R1; ISOLEUCINE; LEUCINE; METHIONINE; MUTANT PROTEIN; PROLINE; RETROVIRUS VECTOR; SERINE; STAT1 PROTEIN; UNCLASSIFIED DRUG; VALINE;

AMINO ACID SUBSTITUTION; ANTIGEN EXPRESSION; ARTICLE; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE CONSTRUCT; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MISSENSE MUTATION; MOLECULAR CLONING; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN POLYMORPHISM; PROTEIN VARIANT; SIGNAL TRANSDUCTION; WILD TYPE;

AMINO ACID SUBSTITUTION; CELL LINE; GENE EXPRESSION; HUMANS; MUTATION, MISSENSE; RECEPTORS, INTERFERON;

CORYNEBACTERINEAE;

EID: 74449088925     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.11.016     Document Type: Article

References (44)

1. Allende L.M., Lopez-Goyanes A., Paz-Artal E., Corell A., Garcia-Perez M.A., Varela P., Scarpellini A., Negreira S., Palenque E., and Arnaiz-Villena A. A point mutation in a domain of gamma interferon receptor 1 provokes severe immunodeficiency. Clin. Diagn. Lab Immunol. 8 (2001) 133-137
2. Aoki M., Matsui E., Kaneko H., Inoue R., Fukao T., Watanabe M., Teramoto T., Kato Z., Suzuki K., Suzuki Y., Kasahara K., and Kondo N. A novel single-nucleotide substitution, Leu 467 Pro, in the interferon-gamma receptor 1 gene associated with allergic diseases. Int. J. Mol. Med. 12 (2003) 185-191
3. Bernabei P., Allione A., Rigamonti L., Bosticardo M., Losana G., Borghi I., Forni G., and Novelli F. Regulation of interferon-gamma receptor (INF-gammaR) chains: a peculiar way to rule the life and death of human lymphocytes. Eur. Cytokine Netw. 12 (2001) 6-14
4. Boehm U., Klamp T., Groot M., and Howard J.C. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15 (1997) 749-795
5. Chantrain C.F., Bruwier A., Brichard B., Largent V., Chapgier A., Feinberg J., Casanova J.L., Stalens J.P., and Vermylen C. Successful hematopoietic stem cell transplantation in a child with active disseminated Mycobacterium fortuitum infection and interferon-gamma receptor 1 deficiency. Bone Marrow Transplant. 38 (2006) 75-76
6. de Paus R.A., van de Wetering D., Van Dissel J.T., and van de Vosse E. IL-23 and IL-12 responses in activated human T cells retrovirally transduced with IL-23 receptor variants. Mol. Immunol. 45 (2008) 3889-3895
7. Dorman S.E., Picard C., Lammas D., Heyne K., Van Dissel J.T., Baretto R., Rosenzweig S.D., Newport M., Levin M., Roesler J., Kumararatne D., Casanova J.L., and Holland S.M. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet 364 (2004) 2113-2121
8. Garotta G., Ozmen L., Fountoulakis M., Dembic Z., van Loon A.P., and Stuber D. Human interferon-gamma receptor. Mapping of epitopes recognized by neutralizing antibodies using native and recombinant receptor proteins. J. Biol. Chem. 265 (1990) 6908-6915
9. Glosli H., Stray-Pedersen A., Brun A.C., Holtmon L.W., Tonjum T., Chapgier A., Casanova J.L., and Abrahamsen T.G. Infections due to various atypical mycobacteria in a Norwegian multiplex family with dominant interferon-gamma receptor deficiency. Clin. Infect. Dis. 46 (2008) e23-e27
10. Heemskerk M.H., Blom B., Nolan G., Stegmann A.P., Bakker A.Q., Weijer K., Res P.C., and Spits H. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J. Exp. Med. 186 (1997) 1597-1602
11. Higuchi R., Krummel B., and Saiki R.K. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res. 16 (1988) 7351-7367
12. Jouanguy E., Altare F., Lamhamedi S., Revy P., Emile J.F., Newport M., Levin M., Blanche S., Seboun E., Fischer A., and Casanova J.L. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N. Engl. J. Med. 335 (1996) 1956-1961
13. Jouanguy E., Lamhamedi-Cherradi S., Altare F., Fondaneche M.C., Tuerlinckx D., Blanche S., Emile J.F., Gaillard J.L., Schreiber R., Levin M., Fischer A., Hivroz C., and Casanova J.L. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis. J Clin. Invest. 100 (1997) 2658-2664
14. Jouanguy E., Lamhamedi-Cherradi S., Lammas D., Dorman S.E., Fondaneche M.C., Dupuis S., Doffinger R., Altare F., Girdlestone J., Emile J.F., Ducoulombier H., Edgar D., Clarke J., Oxelius V.A., Brai M., Novelli V., Heyne K., Fischer A., Holland S.M., Kumararatne D.S., Schreiber R.D., and Casanova J.L. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat. Genet. 21 (1999) 370-378
15. Jouanguy E., Dupuis S., Pallier A., Doffinger R., Fondaneche M.C., Fieschi C., Lamhamedi-Cherradi S., Altare F., Emile J.F., Lutz P., Bordigoni P., Cokugras H., Akcakaya N., Landman-Parker J., Donnadieu J., Camcioglu Y., and Casanova J.L. In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma. J. Clin. Invest. 105 (2000) 1429-1436
16. Kaplan D.H., Shankaran V., Dighe A.S., Stockert E., Aguet M., Old L.J., and Schreiber R.D. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 7556-7561
17. Klausner R.D., and Sitia R. Protein degradation in the endoplasmic reticulum. Cell 62 (1990) 611-614
18. Leenen P.J., Canono B.P., Drevets D.A., Voerman J.S., and Campbell P.A. TNF-alpha and IFN-gamma stimulate a macrophage precursor cell line to kill Listeria monocytogenes in a nitric oxide-independent manner. J. Immunol. 153 (1994) 5141-5147
19. Nakao F., Ihara K., Kusuhara K., Sasaki Y., Kinukawa N., Takabayashi A., Nishima S., and Hara T. Association of IFN-gamma and IFN regulatory factor 1 polymorphisms with childhood atopic asthma. J. Allergy Clin. Immunol. 107 (2001) 499-504
20. Nakashima H., Inoue H., Akahoshi M., Tanaka Y., Yamaoka K., Ogami E., Nagano S., Arinobu Y., Niiro H., Otsuka T., and Niho Y. The combination of polymorphisms within interferon-gamma receptor 1 and receptor 2 associated with the risk of systemic lupus erythematosus. FEBS Lett. 453 (1999) 187-190
21. Nathan C.F., and Hibbs Jr. J.B. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3 (1991) 65-70
22. Newport M.J., Huxley C.M., Huston S., Hawrylowicz C.M., Oostra B.A., Williamson R., and Levin M. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335 (1996) 1941-1949
23. Noordzij J.G., Hartwig N.G., Verreck F.A., De Bruin-Versteeg S., de Boer T., Dissel J.T., De Groot R., Ottenhoff T.H., and Van Dongen J.J. Two patients with complete defects in interferon gamma receptor-dependent signaling. J. Clin. Immunol. 27 (2007) 490-496
24. Novick D., Fischer D.G., Reiter Z., Eshhar Z., and Rubinstein M. Monoclonal antibodies to the human interferon-gamma receptor: blocking of the biological activities of interferon-gamma and purification of the receptor. J. Interferon Res. 9 (1989) 315-328
25. Okada S., Ishikawa N., Shirao K., Kawaguchi H., Tsumura M., Ohno Y., Yasunaga S., Ohtsubo M., Takihara Y., and Kobayashi M. The novel IFNGR1 mutation 774del4 produces a truncated form of interferon-gamma receptor 1 and has a dominant-negative effect on interferon-gamma signal transduction. J. Med. Genet. 44 (2007) 485-491
26. Ottenhoff T.H., Verreck F.A., Lichtenauer-Kaligis E.G., Hoeve M.A., Sanal O., and Van Dissel J.T. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic Mycobacteria and Salmonellae. Nat. Genet. 32 (2002) 97-105
27. Pierre-Audigier C., Jouanguy E., Lamhamedi S., Altare F., Rauzier J., Vincent V., Canioni D., Emile J.F., Fischer A., Blanche S., Gaillard J.L., and Casanova J.L. Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin. Infect. Dis. 24 (1997) 982-984
28. Platanias L.C., and Fish E.N. Signaling pathways activated by interferons. Exp. Hematol. 27 (1999) 1583-1592
29. Ramana C.V., Gil M.P., Schreiber R.D., and Stark G.R. Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. Trends Immunol. 23 (2002) 96-101
30. Remiszewski P., Roszkowska-Sliz B., Winek J., Chapgier A., Feinberg J., Langfort R., Bestry I., Augustynowicz-Kopec E., Ptak J., Casanova J.L., and Rowinska-Zakrzewska E. Disseminated Mycobacterium avium infection in a 20-year-old female with partial recessive IFNgammaR1 deficiency. Respiration 73 (2006) 375-378
31. Roesler J., Kofink B., Wendisch J., Heyden S., Paul D., Friedrich W., Casanova J.L., Leupold W., Gahr M., and Rosen-Wolff A. Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options. Exp. Hematol. 27 (1999) 1368-1374
32. Rosenzweig S., Dorman S.E., Roesler J., Palacios J., Zelazko M., and Holland S.M. 561del4 defines a novel small deletion hotspot in the interferon-gamma receptor 1 chain. Clin. Immunol. 102 (2002) 25-27
33. Schroder K., Hertzog P.J., Ravasi T., and Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75 (2004) 163-189
34. Shang X.Z., and Issekutz A.C. Contribution of CD11a/CD18, CD11b/CD18, ICAM-1 (CD54) and -2 (CD102) to human monocyte migration through endothelium and connective tissue fibroblast barriers. Eur. J. Immunol. 28 (1998) 1970-1979
35. SNP database, build: 130, 2006. http://www.ncbi.nlm.nih.gov/sites/entrez?db=snp&cmd=search&term=rs17175322.
36. Tanaka Y., Nakashima H., Hisano C., Kohsaka T., Nemoto Y., Niiro H., Otsuka T., Otsuka T., Imamura T., and Niho Y. Association of the interferon-gamma receptor variant (Val14Met) with systemic lupus erythematosus. Immunogenetics 49 (1999) 266-271
37. Thye T., Burchard G.D., Nilius M., Muller-Myhsok B., and Horstmann R.D. Genomewide linkage analysis identifies polymorphism in the human interferon-gamma receptor affecting Helicobacter pylori infection. Am. J. Hum. Genet. 72 (2003) 448-453
38. Valente G., Ozmen L., Novelli F., Geuna M., Palestro G., Forni G., and Garotta G. Distribution of interferon-gamma receptor in human tissues. Eur. J. Immunol. 22 (1992) 2403-2412
39. van Boxel-Dezaire A.H., and Stark G.R. Cell type-specific signaling in response to interferon-gamma. Curr. Top. Microbiol. Immunol. 316 (2007) 119-154
40. van de Stolpe A., and van der Saag P.T. Intercellular adhesion molecule-1. J. Mol. Med. 74 (1996) 13-33
41. van de Vosse E., Hoeve M.A., and Ottenhoff T.H. Human genetics of intracellular infectious diseases: molecular and cellular immunity against Mycobacteria and Salmonellae. Lancet Infect. Dis. 4 (2004) 739-749
42. van de Vosse E., de Paus R.A., Van Dissel J.T., and Ottenhoff T.H. Molecular complementation of IL-12Rbeta1 deficiency reveals functional differences between IL-12Rbeta1 alleles including partial IL-12Rbeta1 deficiency. Hum. Mol. Genet. 14 (2005) 3847-3855
43. Walter M.R., Windsor W.T., Nagabhushan T.L., Lundell D.J., Lunn C.A., Zauodny P.J., and Narula S.K. Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor. Nature 376 (1995) 230-235
44. Watzka H., Pfizenmaier K., and Moosmayer D. Guided selection of antibody fragments specific for human interferon gamma receptor 1 from a human VH- and VL-gene repertoire. Immunotechnology 3 (1998) 279-291